NCT05078723

Brief Summary

The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Oct 2021Dec 2026

First Submitted

Initial submission to the registry

July 1, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 14, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

October 30, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

4.3 years

First QC Date

July 1, 2021

Last Update Submit

December 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Breath limonene value in parts per billion

    The amount of limonene in the breath will be measured by mass spectrometry for each participant.

    2 hours

Study Arms (2)

CYP2C19*2 and CYP2C19*3 Variants

EXPERIMENTAL

The group of participants has been genotyped to have the CYP2C19\*2 and/or CYP2C19\*3 variant during the first part of the study. The participants will consume 1 oz water mixed with 500mg limonene (Jarrow Formula orange peel extract) and be asked to swish 5 times and swallow. All participants will then provide breath samples over the course of 2 hours. The breath sample outcomes will be compared to those of the wild-type CYP2C19 study subjects.

Dietary Supplement: Limonene

Wildtype CYP2C19

EXPERIMENTAL

The group of participants has been genotyped to have wild-type CYP2C19. The participants will consume 1 oz water mixed with 500mg limonene (Jarrow Formula orange peel extract) and be asked to swish 5 times and swallow. All participants will then provide breath samples over the course of 2 hours. The breath sample outcomes will be compared to those of the CYP2C19\*2 and/or CYP2C19\*3 study subjects.

Dietary Supplement: Limonene

Interventions

LimoneneDIETARY_SUPPLEMENT

The investigators will ask the participants to swish 5 times and swallow 1 oz water mixed with 500mg limonene (Jarrow Formula orange peel extract). The participant will be monitored for a total of 2 hours. Breath samples will be acquired at a total of 11 time points throughout the study. Measurements include 2 baseline measurements followed by the orange peel extract consumption.

CYP2C19*2 and CYP2C19*3 VariantsWildtype CYP2C19

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age range: Greater than 18 years and less than 45 years.
  • Gender: Male or Female
  • Ethnicities: East Asian

You may not qualify if:

  • Pregnant and/or Breastfeeding
  • previous allergic reaction to limonene, citrus fruits, bovine gelatin, glycerin
  • past medical history of cerebrovascular or cardiovascular disease
  • veganism
  • history of chest pain or shortness of breath in the past month
  • certain medications that are CYP2C19 substrates or CYP2C19 inhibitors
  • Non-East Asian descent
  • age less than 18 y.o or age greater than 45 y.o

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford School of Medicine

Stanford, California, 94305, United States

RECRUITING

MeSH Terms

Interventions

Limonene

Intervention Hierarchy (Ancestors)

Cyclohexane MonoterpenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsCyclohexenesMonoterpenesTerpenes

Central Study Contacts

Eric Gross, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
We are using quantitative assays for this study which reduce the need for masking of the participant or investigator.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Human volunteers participating in this study will be given an over the counter orange peel extract and limonene levels will be measured.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 1, 2021

First Posted

October 14, 2021

Study Start

October 30, 2021

Primary Completion

March 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations